Skip to main content
ZYMEHealthcare

Zymeworks BC Inc (ZYME) Insider Trading

In the last 90 days, 1 Zymeworks BC Inc (ZYME) insider reported no open-market purchases and 1 sale totaling $357,557. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 9, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 9, 2026Adam SchayowitzEVP, Head of R&DSale13,832$25.85$357,557

Common questions

ZYME insider trading FAQ

Are ZYME insiders buying or selling?
Over the last 90 days, ZYME insiders were net sellers, reporting $0.00 of open-market purchases and $357,557 of sales.
When was the last ZYME insider purchase?
No open-market insider purchase of Zymeworks BC Inc stock was reported in the last 90 days.
Where does ZYME insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Zymeworks BC Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.